Clinical trials
Active, not recruiting Phase 2 Lymphoma, Follicular trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 5 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 27 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 4 |
| Celgene | 2 |
| City of Hope Medical Center | 2 |
| Olivia Newton-John Cancer Research Institute | 2 |
| Xynomic Pharmaceuticals, Inc. | 2 |
| Fondazione Italiana Linfomi - ETS | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| M.D. Anderson Cancer Center | 1 |
| McMaster University | 1 |
| MeiraGTx, LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Follicular | 27 |
| Lymphoma, B-Cell, Marginal Zone | 5 |
| Lymphoma, Large B-Cell, Diffuse | 4 |
| Lymphoma, Mantle-Cell | 4 |
| Lymphoma, Non-Hodgkin | 4 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
| Lymphoma | 3 |
| Lymphoma, B-Cell | 3 |
| Recurrence | 3 |
| Waldenstrom Macroglobulinemia | 2 |
Trials
Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.